About Rush University Medical Center - University Cardiovascular Surgeons
"Rush University Medical Center offers next-day appointments in several surgical specialties Monday through Saturday, whether for an initial consultation or a second opinion. To schedule your consultation, call (888) 352-RUSH (7874)."
Clinical Trials at Rush University Medical Center - University Cardiovascular Surgeons
During the past decade, Rush University Medical Center - University Cardiovascular Surgeons conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Rush University Medical Center - University Cardiovascular Surgeons"
#1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator and "Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Rush University Medical Center - University Cardiovascular Surgeons
According to Clinical.Site data, the most researched conditions in "Rush University Medical Center - University Cardiovascular Surgeons" are
"Crohn Disease" (3 trials), "Antibody-mediated Rejection" (1 trials), "Liver Cirrhosis" (1 trials), "Myelofibrosis" (1 trials) and "Non-Alcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Rush University Medical Center - University Cardiovascular Surgeons" in a lesser frequency.
Clinical Trials Intervention Types at Rush University Medical Center - University Cardiovascular Surgeons
Most popular intervention types in "Rush University Medical Center - University Cardiovascular Surgeons" are "Drug" (7 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "CC-90001" (1 trials), "Clazakizumab" (1 trials) and "EDP-305 1.5 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Rush University Medical Center - University Cardiovascular Surgeons
The vast majority of trials in "Rush University Medical Center - University Cardiovascular Surgeons" are
7 trials for "All" genders.
Clinical Trials Status at Rush University Medical Center - University Cardiovascular Surgeons
Currently, there are NaN active trials in "Rush University Medical Center - University Cardiovascular Surgeons".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Rush University Medical Center - University Cardiovascular Surgeons,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Rush University Medical Center - University Cardiovascular Surgeons, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".